Market research
MD Mednax Inc
NYSE USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- 12.71
- Analyst target
- 26.3333
- Dividend yield
- Not available
- Beta
- 0.65
Profile
Company facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- US58502B1061
- Market cap
- 2B
- P/E ratio
- 12.71
- Analyst target
- 26.3333
- Dividend yield
- Not available
- Beta
- 0.65
About
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the MD discussion.
5 years, 4 months ago
MEDNAX, Inc is currently in a long term uptrend where the price is trading 17.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
MEDNAX, Inc's total revenue sank by 54.0% to $417M since the same quarter in the previous year.
Its net income has dropped by 789.1% to $-64M since the same quarter in the previous year.
Finally, its free cash flow fell by 115.6% to $-19M since the same quarter in the previous year.
Based on the above factors, MEDNAX, Inc gets an overall score of 2/5.